This is filed for atrial tachycardia.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 4+ with a restricted posterior leaflet and a dilated left atrium.One mitraclip was deployed at a2/p2 medial portion.A second mitraclip (90729u134) was deployed at a2/p2 lateral portion, reducing mr to 1-2.Once the clip delivery system (cds) was retracted, atrial tachycardia was noted.After the procedure, cardioversion was performed and the heart rate returned to sinus rhythm.The patient is doing well and stable.There was no clinically significant delay in the procedure.No additional information was provided.
|
G9: exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.The reported patient effect of arrhythmias (tachycardia), as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.All information was investigated, and a cause for the reported atrial tachycardia could not be determined.Although a conclusive cause for the reported patient effect, and the relationship to the device, if any, cannot be determined, there is no indication of a product quality issue with respect to manufacture, design or labeling.
|